Insider filing · APGE
Peter Evan Harwin
Director
profile →
Apogee Therapeutics, Inc.
APGE · Healthcare · 47 filings in 24 months
ticker →
Peter Evan Harwin sold $133.5M of Apogee Therapeutics (APGE)
Executed Jan 22, disclosed Jan 22, the same day.
Value, as filed
$133.5M
1,750,000 sh × $76.30
Executed
Jan 22
the trade date, as filed
Disclosed
Jan 22
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
PHPeter Evan Harwin (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Apogee Therapeutics, Inc. (APGE). The largest single filing was $133.5M of APGE (1,750,000 sh × $76.30, as filed), executed Jan 22.
The name
APGEHealthcare · Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma,…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→